Clinical Trials Browser

Phase 3 × Arthritis, Rheumatoid × Rituximab × Clear all

NCT00503425 2017-08-15

A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Phase 3 Completed

215 enrolled 9 charts

Arthritis, Rheumatoid

NCT00468546 2016-10-25

A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

Phase 3 Completed

520 enrolled 17 charts

Arthritis, Rheumatoid